NINJA: an inducible genetic model for creating neoantigens in vivo
M. Damo, B. Fitzgerald, Y. Lu, M. Nader, I. William, J. Cheung, K. A. Connolly, G. G. Foster, E. Akama-Garren, D.-Y. Lee, G. P. Chang, V. Gocheva, L. M. Schmidt, A. Boileve, J. H. Wilson, C. Cui, I. Monroy, P. R. Gokare, P. Cabeceiras, T. Jacks, N. S. Joshi
Abstract
Mouse models with inducible neoantigens have been historically difficult to generate because of leaky expression of antigens in the thymus, which causes central tolerance in developing CD8 and CD4 T cells. Attempts to resolve this problem using existing genetic tools have been unsuccessful. We developed the iNversion INducible Joined neoAntigen (NINJA) mouse model that uses RNA splicing, DNA recombination, and three levels of regulation to prevent neoantigen leakiness and allow tight control over the induction of neoantigen expression. We describe the development of these genetic tools and their use for obtaining tumor cell lines with inducible neoantigen expression. Moreover, we show that the genetic regulation in NINJA mice bypasses central and peripheral tolerance mechanisms and allows for robust endogenous CD8 and CD4 T cells responses upon neoantigen induction in peripheral tissues. Thus, NINJA fills a long-standing gap in the field and will enable studies of how T cells respond to defined neoantigens in the context of peripheral tolerance, autoimmune diseases, and developing tumors.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mice generated with induced pluripotent stem cells derived from mucosal-associated invariant T cells
C. Sugimoto, H. Fujita, H. Wakao·bioRxiv·Jul 27, 2022
- Neoantigens drive adoptively transferred CD8 T cells to long-lived effectors mediated by lymph node trafficking
Megen C Wittling, Amalia M. Rivera-Reyes, … Hannah M. Knochelmann·bioRxiv·Apr 18, 2025
- Decoupled neoantigen cross-presentation in tumors with high intratumor heterogeneity reduces dendritic cell activation to limit anti-tumor immunity
K. B. Nguyen, C. J. Copeland, … S. Spranger·bioRxiv·Dec 16, 2022
- A Framework for Comparing Mouse Neoantigen Immunogenicity
Peter J Matulich, Carly Sprague, … Megan L. Burger·bioRxiv·Oct 13, 2026
- Predicting Neoantigen Immunogenicity from In Vivo Immune Editing
Timothy J. Sears, Ko-Han Lee, … Hannah K. Carter·bioRxiv·Sep 18, 2026
- CD40 and CD80/86 signaling in cDC1s mediate effective neoantigen vaccination and generation of antigen-specific CX3CR1+ CD8+ T cells in mice
T. Yamauchi, T. Hoki, … F. Ito·bioRxiv·Jun 15, 2020